| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.6M | — | +9.8% |
| R&D Expense | $20.9M | — | -24.6% |
| SG&A Expense | $9.0M | — | -29.9% |
| Operating Income | -$11.3M | — | +52.2% |
| Pre-tax Income | -$11.9M | — | +47.5% |
| Income Tax | $24K | — | +105.8% |
| Net Income | -$11.9M | — | +46.4% |
| EPS (Basic) | -$0.42 | — | +60.0% |
| EPS (Diluted) | -$0.42 | — | +60.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $37.4M | +15.9% | -55.6% |
| Accounts Receivable | $8.5M | +23.4% | +10.0% |
| Current Assets | $198.7M | -2.8% | -25.9% |
| Total Assets | $329.5M | +17.4% | -5.5% |
| Current Liabilities | $44.7M | -7.9% | -8.8% |
| Total Liabilities | $202.9M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.7M | — | +30.4% |
| Capital Expenditures | $143K | — | -98.4% |
| Investing Cash Flow | -$47.3M | — | -168.6% |
| Financing Cash Flow | $64.1M | — | +1386.3% |
| Free Cash Flow | -$11.8M | — | +53.6% |
| -14.3% |
| Stockholders' Equity | $126.6M | +95.6% | +13.2% |